• New Microsoft Smartphone App Helps ALS Patients Communicate Faster
  • New Method to Measure RNA Decay May Help Identify ALS Therapies
  • Orangetheory, Augie’s Quest Launch $1M Fundraising Campaign for ALS Research
  • Disease Strikes Children of ALS Parents with C9orf72 Mutations at Younger Ages, Study Finds
  • Interview with Prize4Life and French Team That Won $1M Award for ‘Effective’ ALS Gene Therapy Approach
  • Neuraltus Enrolls Nearly Half of Patients in Phase 2 Confirmation Trial of NP001 for ALS
  • Researchers Develop New Molecule, 123C4, with Possibility to Treat ALS
  • Most with Chronic Conditions Find Affordable Care Act Beneficial, Poll Shows
  • GeNeuro, NIH to Jointly Develop Novel ALS Antibody Treatment
  • Heavy Metal Pollution May Not Lead to Higher ALS Incidence, Italian Study Suggests
  • Using Probiotics to Restore Gut Bacteria Balance May Help with ALS, Researchers Say
  • Ozanezumab Fails to Show Benefit as ALS Treatment in Phase 2 Clinical Trial